Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Preclinical study confirms antiinflammatory activity of raxofelast

Feb. 25, 1999

ICE/ced-3 cysteine protease inhibitors in development at Idun

Feb. 25, 1999

Connetics begins pivotal trial of relaxin for scleroderma therapy

Feb. 25, 1999

Experiments show skeletal muscle capable of bone formation when transplanted into animals

Feb. 25, 1999

Phase III enrollment for Colloral completed

Feb. 24, 1999

Autoimmune antibodies linked to blood clotting defect

Feb. 23, 1999

Calmodulin analogues with antiinflammatory activity available for licensing from OMRF

Feb. 23, 1999

Roche discloses inhibitors of TNF-alpha/TGF-alpha release, keratinocyte proliferation

Feb. 18, 1999

VUFB's phase III antirheumatic agent is available for licensing

Feb. 18, 1999

More from SmithKline Beecham on p38 MAP kinase inhibitors

Feb. 18, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...